Pooled trials found less major bleeding with factor XIa inhibitors
In patients at risk of stroke or blood clots, pooled trials found less major bleeding with factor XIa inhibitors, while clot-prevention differences remained uncertain.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The pooled trials found less major bleeding with factor XIa inhibitors. They did not detect statistically significant differences in clot-related events, ischemic stroke, death, or other reported safety outcomes. These uncertain findings do not establish equal clot prevention. Conflicting evidence in atrial fibrillation, an irregular heart rhythm, leaves the overall clinical benefit unresolved.
The abstract reports variation across studies and subgroups, particularly conflicting clot-related findings in atrial fibrillation. It does not provide follow-up duration, absolute bleeding rates, or separate comparator-specific estimates.
What researchers found
Major bleeding
Relative risk 0.47 (95% confidence interval 0.33–0.66), versus pooled placebo or direct oral anticoagulants. Follow-up duration not reported.
Understanding the relative comparison
The risk ratio compares bleeding risk between treatment and control groups. It expresses a relative difference, not an absolute reduction. Without absolute bleeding rates, the abstract cannot show how many patients avoided major bleeding.
Clot prevention remains uncertain
Major bleeding and clot prevention are separate outcomes. Nonsignificant clot-related results leave treatment differences uncertain rather than proving equivalence. The authors call for larger trials to clarify clinical benefit across patient groups.
The original publication
The safety and efficacy of factor XIa inhibitors for the prevention of stroke and thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
Zahid N, Iqbal F, Siddique A et al.
J Stroke Cerebrovasc Dis · 2025
- PubMed ID
- 40543905
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.